|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vanishing bile duct syndrome in human immunodeficiency virus infected adults:A report of two cases显示文摘Vanishing bile duct syndrome(VBDS) is a group of rare disorders characterized by ductopenia,the progressive destruction and disappearance of intrahepatic bile ducts leading to cholestasis.Described in association with medications,autoimmune disorders,cancer,transplantation,and infections,the specific mechanisms of disease are not known.To date,only 4 cases of VBDS have been reported in human immunodeficiency virus(HIV) infected patients.We report 2 additional cases of HIV-associated VBDS and review the features common to the HIV-associated cases.Presentation includes hyperbilirubinemia,normal liver imaging,and negative viral and autoimmune hepatitis studies.In HIV-infected subjects,VBDS occurred at a range of CD4+ T-cell counts,in some cases following initiation or change in antiretroviral therapy.Lymphoma was associated with two cases;nevirapine,antibiotics,and viral co-infection were suggested as etiologies in the other cases.In HIV-positive patients with progressive cholestasis,early identification of VBDS and referral for transplantation may improve outcomes. | Ana Paula Oppenheimer Christopher Koh Mary McLaughlin John C Williamson Thomas D Norton Jennifer Laudadio Theo Heller David E Kleiner Kevin P High Caryn G Morse | 2013 | World Journal of Gastroenterology2013，19，1： | 8 |
| 2 | Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis显示文摘 | Conway B McLaughlin M Sharpe P | 2005 | Nephrol Dial Transplant2005，20，12： | 1 |
| 3 | Rituxmab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program显示文摘 | Mclaughlin P Grillo Lopez A J Link B K | 1998 | J Clin Oncol1998，16，8： | 1 |
| 4 | Fludarabine, mitoxantrone and dexamethasone: an effective new regimen for indolent lymphoma 显示文摘 | MCLAUGHLIN P HAGEMEISTER F B ROMAGUERA J E | 1996 | J Clin Oncol1996，14，： | 1 |
| 5 | Prevention of elevated cholesterolemia in monkeys by alfalfa saponins显示文摘 | Mallnow M Mclaughlin P Kohler G | 1977 | Ster- oids1977，29，1： | 1 |
| 6 | Strategies for globalizing service operations 显示文摘 | McLaughlin C P Fitzsimmons J A | 1996 | International Journal of Service Industry1996，7，4： | 1 |
| 7 | Effect of Long-term with Reclaimed Water on Soils of the Northern Adelaide Plains,South Australian显示文摘 | STEVENS D P MCLAUGHLIN M J SMART M K | 2003 | Australian Journal of Soil Research2003，41，5： | 1 |
| 8 | Foren-sic surface metrology : Tool mark evidence 显示文摘 | GAMBINO C MCLAUGHLIN P KUO L | 2011 | Scan-ning2011，33，5： | 1 |
| 9 | The chemistry and biology of febrifugine and halofuginone显示文摘 | Mclaughlin N P Evans P Pines M | 2014 | Bioorganic & Medicinal Chemistry2014，22，7： | 1 |
| 10 | Opioid gene expression in the developing and adult rat heart显示文摘 | MCLAUGHLIN P J WU Y | 1998 | Dev Dyn1998，211，2： | 1 |
| 11 | Phase Ⅱ study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma 显示文摘 | GOY A YOUNES A MCLAUGHLIN P | 2005 | J Clin Oncol2005，23，： | 1 |
| 12 | Security and privacy challenges in the smart grid显示文摘 | Mcdaniel P Mclaughlin S | 2009 | IEEE Security and Privacy2009，7，3： | 1 |
| 13 | The OGF- OGFr axis utilizes the pl6INK4a and p21 WAF1/CIP1 pathways to restrict normal cell proliferationl显示文摘 | Cheng F McLaughlin P J Yerderame M F | 2009 | Mol Biol Cell2009，20，1： | 1 |
| 14 | ESHAP-an effective chemotherapy regimin in refractory and relapsing lymphoma: a 4-year follow-up study显示文摘 | McLaughlin P Tucker S | 1994 | J Clin Oncol1994，12，6： | 1 |
| 15 | Opioids and differentiation in hu- man cancer cellsl显示文摘 | Zagon I S McLaughlin P J | 2005 | Neuropeptides2005，39，5： | 1 |
| 16 | Ethylene from ethanol over zeolite catalysts显示文摘 | MAO L V R LEVESQUE P MCLAUGHLIN G | 1987 | Applied Catalysis1987，34，： | 1 |
| 17 | Microvascular decompression of cranialnerves: lesions learned after 4400 operations显示文摘 | Mclaughlin MR Jannetta P J Clycle BL | 1999 | J Neurosurg1999，90，： | 1 |
| 18 | Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:half of patients respond to a four-dose treatment program 显示文摘 | Mclaughlin P Grillo-Lopez AJ Link BK | 1998 | J Clin Oncol1998，16，8： | 1 |
| 19 | Phase Ⅱ study of rituximab in combination with CHOP chemotherapy in patients with previously untreated,aggressive non-Hodgkin's lymphoma显示文摘 | Vose J M Link B K McLaughlin B P | 2001 | J Clin Oncol2001，19，5： | 1 |
| 20 | Mortality after hip fi'a('tures in Thailand 显示文摘 | Mclaughlin J Ruriyawongpisal P Thak- kinstain A | 2001 | Int Orthop2001，25，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员